(Q38972576)

English

Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

Gerhard Ehninger

7

object named as

Gerhard Ehninger

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Michael Bachmann

8

object named as

Michael Bachmann

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

2

object named as

Anja Feldmann

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1

object named as

Claudia Arndt

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Stefanie Koristka

3

object named as

Stefanie Koristka

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

6

object named as

Armin Ehninger

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Marc Cartellieri

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Maria Dimmel

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

22 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1335-1346

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Prostate cancer as a model for tumour immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Clinical practice. Localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Bispecific antibodies for cancer immunotherapy: Current perspectives

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

BiTEs: bispecific antibody constructs with unique anti-tumor activity

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Bispecific T-cell engaging antibodies for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Blinatumomab: a historical perspective

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Prostate stem cell antigen: a prospective therapeutic and diagnostic target

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Identification of La ribonucleoproteins as a component of interchromatin granules

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Coomassie-Brilliant Blue staining of polyacrylamide gels.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Retargeting of human regulatory T cells by single-chain bispecific antibodies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigens.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targeting.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22850

21 January 2018

Identifiers

10.1002/PROS.22850

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38972576&oldid=1856131767"